Teva Comments On Generic Lovenox(R) Approval
 

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) commented on the U.S. Food and Drug Administration's response to a citizen petition questioning the approval criteria for a generic Lovenox® (enoxaparin sodium) injection and its subsequent approval of another generic filer's Abbreviated New Drug Application (ANDA)...

للمزيد...